NCT00286884

Brief Summary

The aim of the study is to investigate heart rate variability in patients with white coat hypertension and patients with essential hypertension.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2006

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 6, 2006

Completed
Last Updated

September 11, 2006

Status Verified

September 1, 2006

First QC Date

February 3, 2006

Last Update Submit

September 8, 2006

Conditions

Essential HypertensionWhite Coat HypertensionHealthy

Interventions

Monitoring of heart rate variabilityPROCEDURE

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 30-70 years
  • office BP \>150/95 mmHg and 24-h ambulatory BP =/\>135/85 mmHg
  • office BP \>150/95 mmHg and 24-h ambulatory BP \<135/85 mmHg
  • office BP \<150/95 mmHg and 24-h ambulatory BP \<135/85 mmHg

You may not qualify if:

  • Clinical signs of disease of the heart, lungs, liver, kidneys, brain or endocrine organs
  • neoplastic disease
  • daily use of medicine
  • alcohol abuse
  • abnormal laboratory screening including blood-hemoglobin, blood-white cell count, plasma-creatinine, plasma-alanine-amino-transaminases, plasma-albumin, plasma-sodium, plasma-potassium, urinary glucose, urinary albumin; electrocardiogram
  • pregnancy
  • unwillingness to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Medical Research, Holstebro Hospital

Holstebro, 7500, Denmark

Location

MeSH Terms

Conditions

Essential HypertensionWhite Coat Hypertension

Condition Hierarchy (Ancestors)

HypertensionVascular DiseasesCardiovascular Diseases

Study Officials

  • Line B Madsen, MD

    Regional Hospital Holstebro

    PRINCIPAL INVESTIGATOR

  • Erling B Pedersen, MD

    Regional Hospital Holstebro

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 3, 2006

First Posted

February 6, 2006

Last Updated

September 11, 2006

Record last verified: 2006-09

Locations

DK(1)